Abstract
Because most potential molecular markers and targets are proteins, proteomic profiling is expected to yield more direct answers to functional and pharmacological questions than does transcriptional profiling. To aid in such studies, we have developed a protocol for making reverse-phase protein lysate microarrays with larger numbers of spots than previously feasible. Our first application of these arrays was to profiling of the 60 human cancer cell lines (NCI-60) used by the National Cancer Institute to screen compounds for anticancer activity. Each glass slide microarray included 648 lysate spots representing the NCI-60 cell lines plus controls, each at 10 two-fold serial dilutions to provide a wide dynamic range. Mouse monoclonal antibodies and the catalyzed signal amplification system were used for immunoquantitation. The signal levels from the >30,000 data points for our first 52 antibodies were analyzed by usingp-scanand a quantitative dose interpolation method. Clustered image maps revealed biologically interpretable patterns of protein expression. Among the principal early findings from these arrays were two promising pathological markers for distinguishing colon from ovarian adenocarcinomas. When we compared the patterns of protein expression with those we had obtained for the same genes at the mRNA level by using both cDNA and oligonucleotide arrays, a striking regularity appeared: cell-structure-related proteins almost invariably showed a high correlation between mRNA and protein levels across the NCI-60 cell lines, whereas non-cell-structure-related proteins showed poor correlation.
Bibliography
Nishizuka, S., Charboneau, L., Young, L., Major, S., Reinhold, W. C., Waltham, M., Kouros-Mehr, H., Bussey, K. J., Lee, J. K., Espina, V., Munson, P. J., Petricoin, E., Liotta, L. A., & Weinstein, J. N. (2003). Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proceedings of the National Academy of Sciences, 100(24), 14229â14234.
Authors
14
- Satoshi Nishizuka (first)
- Lu Charboneau (additional)
- Lynn Young (additional)
- Sylvia Major (additional)
- William C. Reinhold (additional)
- Mark Waltham (additional)
- Hosein Kouros-Mehr (additional)
- Kimberly J. Bussey (additional)
- Jae K. Lee (additional)
- Virginia Espina (additional)
- Peter J. Munson (additional)
- Emanuel Petricoin (additional)
- Lance A. Liotta (additional)
- John N. Weinstein (additional)
References
31
Referenced
389
10.1016/S0021-9258(19)41496-8
-
Haab, B. B., Dunham, M. J. & Brown, P. O. (2001) Genome Biol. 2, research0004.1–0004.13.11182887
(
10.1186/gb-2001-2-2-research0004
) / Genome Biol. (2001) 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6
10.1038/sj.onc.1204265
10.1126/science.275.5298.343
10.1002/elps.1150180351
10.1093/jnci/81.14.1088
10.1093/jnci/83.11.757
- Stinson, S. F., Alley, M. C., Kopp, W. C., Fiebig, H. H., Mullendore, L. A., Pittman, A. F., Kenney, S., Keller, J. & Boyd, M. R. (1992) Anticancer Res. 12, 1035–1053.1503399 / Anticancer Res. (1992)
- Alley, M. C., Scudiero, D. A., Monks, A., Hursey, M. L., Czerwinski, M. J., Fine, D. L., Abbot, B. J., Mayo, J. G., Shoemaker, R. H. & Boyd, M. R. (1988) Cancer Res. 48, 589–601.3335022 / Cancer Res. (1988)
10.1038/73439
10.1038/73432
10.1073/pnas.191368598
10.1016/S1471-4892(02)00185-6
10.1002/cyto.10041
- Roschke A. V. Tonon G. Gehlhaus K. S. McTyre N. Bussey K. J. Lababidi S. Scudiero D. A. Weinstein J. N. & Kirsch I. R. Cancer Res. in press.
10.1016/S1535-6108(03)00086-2
10.1002/elps.1150180333
10.1128/MCB.19.3.1720
10.1126/science.292.5518.929
10.1002/elps.1150121110
10.1002/(SICI)1098-2744(200005)28:1<12::AID-MC3>3.0.CO;2-Q
- Bussey, K. J., Kane, D., Sunshine, M., Narasimhan, S., Nishizuka, S., Reinhold, W. C., Zeeberg, B., Ajay, W. & Weinstein, J. N. (2003) Genome Biol. 4, R27.1–R27.7.12702208 / Genome Biol. (2003)
- Lee J. K. Bussey K. J. Gwadry F. G. Reinhold W. C. Riddick G. Pelletier S. L. Nishizuka S. Szakacs G. Annereau J.-P. Shankavaram U. et al. Genome Res. in press.
- Nishizuka, S., Chen, S. T., Gwadry, F. G., Alexander, J., Major, S. M., Scherf, U., Reinhold, W. C., Waltham, M., Charboneau, L., Young, L., et al. (2003) Cancer Res. 63, 5243–5250.14500354 / Cancer Res. (2003)
10.1016/0092-8674(80)90330-X
10.1073/pnas.88.19.8297
10.1002/j.1460-2075.1986.tb04618.x
10.1111/j.1432-0436.1993.tb00649.x
10.1073/pnas.91.5.1858
10.1016/0167-4781(95)00090-4
Dates
Type | When |
---|---|
Created | 21 years, 9 months ago (Nov. 25, 2003, 3:59 p.m.) |
Deposited | 8 months, 3 weeks ago (Dec. 14, 2024, 8:51 a.m.) |
Indexed | 3 days, 20 hours ago (Sept. 3, 2025, 5:59 a.m.) |
Issued | 21 years, 9 months ago (Nov. 17, 2003) |
Published | 21 years, 9 months ago (Nov. 17, 2003) |
Published Online | 21 years, 9 months ago (Nov. 17, 2003) |
Published Print | 21 years, 9 months ago (Nov. 25, 2003) |
@article{Nishizuka_2003, title={Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays}, volume={100}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.2331323100}, DOI={10.1073/pnas.2331323100}, number={24}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Nishizuka, Satoshi and Charboneau, Lu and Young, Lynn and Major, Sylvia and Reinhold, William C. and Waltham, Mark and Kouros-Mehr, Hosein and Bussey, Kimberly J. and Lee, Jae K. and Espina, Virginia and Munson, Peter J. and Petricoin, Emanuel and Liotta, Lance A. and Weinstein, John N.}, year={2003}, month=nov, pages={14229–14234} }